We came across a bullish thesis on Capricor Therapeutics, Inc. (CAPR) on wallstreetbets Subreddit Page by androidmj. In this article, we will summarize the bulls’ thesis on CAPR. Capricor Therapeutics, Inc. (CAPR)'s share was trading at $12.65 as of March 5th.
[caption id="attachment_1229694" align="aligncenter" width="768"]Capricor Therapeutics (CAPR) is set for a high-stakes FDA decision on its Duchenne muscular dystrophy (DMD) therapy, Deramiocel (CAP-1002), with...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.